SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0000930413-23-002115
Filing Date
2023-09-07
Accepted
2023-09-07 13:06:16
Documents
101
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 c106868_6ka-ixbrl.htm   iXBRL 6-K/A 153117
2 c106868_ex99-1.htm   iXBRL EX-99.1 606018
  Complete submission text file 0000930413-23-002115.txt   5853568

Data Files

Seq Description Document Type Size
3 alvo-20230831.xsd EX-101.SCH 112377
4 alvo-20230831_cal.xml EX-101.CAL 60054
5 alvo-20230831_def.xml EX-101.DEF 363398
6 alvo-20230831_lab.xml EX-101.LAB 600327
7 alvo-20230831_pre.xml EX-101.PRE 378812
95 EXTRACTED XBRL INSTANCE DOCUMENT c106868_6ka-ixbrl_htm.xml XML 744925
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Filer) CIK: 0001898416 (see all company filings)

IRS No.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-41421 | Film No.: 231241701
SIC: 2836 Biological Products, (No Diagnostic Substances)